Jose Ricardo Perez
Vice President, Genitourinary Portfolio, Medical Affairs Exelixis, Inc.
Jose Ricardo Perez has a rich background in oncology and has been instrumental in the development of innovative cancer treatments at Exelixis. His extensive experience in the pharmaceutical industry, including roles at Novartis, has equipped him with a strategic perspective and vision that has led to significant discoveries and successful outcomes. Perez’s leadership at Exelixis has been marked by a commitment to patient care and a focus on delivering results and new medicines to treat and defeat cancer. His work has not only advanced the company but also contributed to the broader field of oncology by providing hope and new treatments for cancer patients.
Seminars
Wednesday 15th July 2026
Operationalizing Expanded Access in 2026: From Strategy to Scalable Execution
8:30 am
- Understanding how Expanded Access expectations have evolved following recent FDA guidance – and what this means for program design today
- Navigating the realities of implementing global EAPs across regions with differing regulatory frameworks and infrastructure
- Establishing clear ownership: which functions should lead, support, and govern Expanded Access programs as they scale
